GLP-1 drugs like Ozempic gain popularity in Canada for weight loss, with over half of users experiencing reduced appetite and cravings. Many are interested but deterred by high costs, while others see lifestyle changes such as less alcohol consumption and increased spending on personal care and fitness. Common side effects are mild, but rare issues like gallbladder problems may arise. The survey suggests a significant potential user base, with six percent expressing interest but not yet trying the drugs.
Support the show
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai
View sources & latest updates
https://sources.thednn.ai/b55c832701532e56
